دورية أكاديمية
Bioinspired and Green Synthesis of Silver Nanoparticles for Medical Applications: A Green Perspective.
العنوان: | Bioinspired and Green Synthesis of Silver Nanoparticles for Medical Applications: A Green Perspective. |
---|---|
المؤلفون: | Arshad F; Department of Mathematics and Sciences, College of Arts and Applied Sciences, Dhofar University, Salalah, PC 211, Oman., Naikoo GA; Department of Mathematics and Sciences, College of Arts and Applied Sciences, Dhofar University, Salalah, PC 211, Oman. gahmed@du.edu.om., Hassan IU; College of Engineering, Dhofar University, Salalah, PC 211, Oman., Chava SR; Department of Chemistry, Texas A&M University, Kingsville, TX, USA., El-Tanani M; College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah, United Arab Emirates., Aljabali AA; Department of Pharmaceutics and Pharmaceutical Technology, Yarmouk University, Irbid, 21163, Jordan., Tambuwala MM; Lincoln Medical School, University of Lincoln, Brayford Pool Campus, Lincoln, LN6 7TS, UK. mtambuwala@lincoln.ac.uk. |
المصدر: | Applied biochemistry and biotechnology [Appl Biochem Biotechnol] 2024 Jun; Vol. 196 (6), pp. 3636-3669. Date of Electronic Publication: 2023 Sep 05. |
نوع المنشور: | Journal Article; Review |
اللغة: | English |
بيانات الدورية: | Publisher: Humana Press Country of Publication: United States NLM ID: 8208561 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-0291 (Electronic) Linking ISSN: 02732289 NLM ISO Abbreviation: Appl Biochem Biotechnol Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: Clifton, N.J. : Humana Press, c1981- |
مواضيع طبية MeSH: | Silver*/chemistry , Silver*/pharmacology , Metal Nanoparticles*/chemistry , Metal Nanoparticles*/therapeutic use , Green Chemistry Technology*, Humans ; Anti-Infective Agents/pharmacology ; Anti-Infective Agents/chemistry ; Anti-Infective Agents/chemical synthesis ; Plant Extracts/chemistry ; Plant Extracts/pharmacology ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/chemistry ; Antineoplastic Agents/chemical synthesis |
مستخلص: | Silver nanoparticles (AgNPs) possess unmatched chemical, biological, and physical properties that make them unique compounds as antimicrobial, antifungal, antiviral, and anticancer agents. With the increasing drug resistance, AgNPs serve as promising entities for targeted drug therapy against several bacterial, fungal, and viral components. In addition, AgNPs also serve as successful anticancer agents against several cancers, including breast, prostate, and lung cancers. Several works in recent years have been done towards the development of AgNPs by using plant extracts like flowers, leaves, bark, root, stem, and whole plant parts. The green method of AgNP synthesis thus has several advantages over chemical and physical methods, especially the low cost of synthesis, no toxic byproducts, eco-friendly production pathways, can be easily regenerated, and the bio-reducing potential of plant derived nanoparticles. Furthermore, AgNPs are biocompatible and do not harm normally functioning human or host cells. This review provides an exhaustive overview and potential of green synthesized AgNPs that can be used as antimicrobial, antifungal, antiviral, and anticancer agents. After a brief introduction, we discussed the recent studies on the development of AgNPs from different plant extracts, including leaf parts, seeds, flowers, stems, bark, root, and whole plants. In the following section, we highlighted the different therapeutic actions of AgNPs against various bacteria, fungi, viruses, and cancers, including breast, prostate, and lung cancers. We then highlighted the general mechanism of action of AgNPs. The advantages of the green synthesis method over chemical and physical methods were then discussed in the article. Finally, we concluded the review by providing future perspectives on this promising field in nanotechnology. (© 2023. The Author(s).) |
References: | Environ Technol. 2019 Mar;40(8):1071-1078. (PMID: 29385891) J Food Drug Anal. 2014 Mar;22(1):116-127. (PMID: 24673909) J Exp Clin Cancer Res. 2019 Mar 12;38(1):125. (PMID: 30867007) Biomolecules. 2022 Apr 24;12(5):. (PMID: 35625555) Int J Nanomedicine. 2013;8:4103-13. (PMID: 24204140) Sci Rep. 2015 Nov 20;5:16908. (PMID: 26584777) Sci Rep. 2020 Jul 30;10(1):12805. (PMID: 32732959) World J Microbiol Biotechnol. 2019 May 27;35(6):88. (PMID: 31134435) Biotechnol Rep (Amst). 2017 Feb 10;14:1-7. (PMID: 28459002) Molecules. 2020 Jul 31;25(15):. (PMID: 32751780) J Biomater Sci Polym Ed. 2016;27(3):218-34. (PMID: 26540350) Saudi J Biol Sci. 2020 Sep;27(9):2410-2419. (PMID: 32884424) J Nanobiotechnology. 2020 Nov 10;18(1):164. (PMID: 33168016) Front Mol Biosci. 2020 Nov 26;7:587012. (PMID: 33324678) Artif Cells Nanomed Biotechnol. 2018;46(sup3):S1047-S1058. (PMID: 30479160) RSC Adv. 2020 Jun 1;10(35):20676-20681. (PMID: 35517757) J Nanobiotechnology. 2019 Jan 22;17(1):9. (PMID: 30670028) PLoS One. 2020 Jul 2;15(7):e0234964. (PMID: 32614844) Adv Drug Deliv Rev. 2013 Nov;65(13-14):1803-15. (PMID: 23892192) Appl Microbiol Biotechnol. 2016 Aug;100(15):6555-6570. (PMID: 27289481) Toxicol In Vitro. 2014 Oct;28(7):1280-9. (PMID: 24997297) Saudi J Biol Sci. 2022 Apr;29(4):2772-2781. (PMID: 35531187) Nanotechnology. 2020 Apr 9;31(26):265101. (PMID: 32143194) Nanoscale Res Lett. 2017 Dec;12(1):46. (PMID: 28097599) Biochem Biophys Res Commun. 2012 Aug 10;424(4):657-62. (PMID: 22771582) Appl Environ Microbiol. 2009 May;75(9):2973-6. (PMID: 19270121) Mater Sci Eng C Mater Biol Appl. 2018 May 1;86:1-8. (PMID: 29525084) Parasitol Res. 2015 Sep;114(9):3315-25. (PMID: 26063530) Heliyon. 2021 Sep 20;7(9):e08033. (PMID: 34611564) Heliyon. 2021 Apr 30;7(4):e06923. (PMID: 34007921) Fungal Biol. 2020 Jul;124(7):671-681. (PMID: 32540190) Nanomaterials (Basel). 2021 Aug 21;11(8):. (PMID: 34443960) Nanomedicine. 2016 Apr;12(3):601-610. (PMID: 26656631) Acta Biomater. 2014 Jan;10(1):439-49. (PMID: 24095782) Artif Cells Nanomed Biotechnol. 2018;46(sup3):S855-S872. (PMID: 30328732) Nanobiomedicine (Rij). 2021 Feb 16;8:1849543521995310. (PMID: 33643450) Oncotarget. 2017 Dec 23;9(11):9685-9705. (PMID: 29515763) Biomed Res Int. 2014;2014:318030. (PMID: 24999473) J Nanobiotechnology. 2010 Aug 18;8:19. (PMID: 20718972) Sci Rep. 2017 Nov 20;7(1):15867. (PMID: 29158537) J Photochem Photobiol B. 2020 Mar;204:111806. (PMID: 32044619) Adv Colloid Interface Sci. 2011 Dec 12;169(2):59-79. (PMID: 21981929) Biochim Biophys Acta. 2012 Nov;1818(11):2669-78. (PMID: 22705501) J Biotechnol. 2023 Mar 10;365:1-10. (PMID: 36708999) Bioconjug Chem. 2009 Aug 19;20(8):1497-502. (PMID: 21141805) Int J Nanomedicine. 2015 Dec 22;11:55-68. (PMID: 26730190) Adv Exp Med Biol. 2012;942:287-308. (PMID: 22399428) J Nanobiotechnology. 2005 Jun 29;3:6. (PMID: 15987516) Evid Based Complement Alternat Med. 2018 Jun 26;2018:1860280. (PMID: 30046333) Microb Pathog. 2018 Nov;124:63-69. (PMID: 30121359) Int J Environ Res Public Health. 2016 Apr 19;13(4):430. (PMID: 27104546) Adv Healthc Mater. 2018 Jul;7(13):e1701503. (PMID: 29808627) Int J Mol Sci. 2021 Nov 05;22(21):. (PMID: 34769419) J Proteomics. 2020 Jul 30;224:103833. (PMID: 32450145) J Pharm Biomed Anal. 2020 Feb 5;179:113012. (PMID: 31791838) Mater Sci Eng C Mater Biol Appl. 2014 Nov;44:278-84. (PMID: 25280707) Microb Pathog. 2018 Jan;114:402-408. (PMID: 29196171) Nanoscale Res Lett. 2021 Oct 18;16(1):156. (PMID: 34664133) J Phys Chem B. 2014 Dec 11;118(49):14017-26. (PMID: 24779411) J Biochem Mol Toxicol. 2020 May;34(5):e22474. (PMID: 32043710) J Inorg Biochem. 2022 Jun;231:111802. (PMID: 35364443) AMB Express. 2021 Apr 26;11(1):61. (PMID: 33900505) J Photochem Photobiol B. 2020 Jan;202:111713. (PMID: 31760373) Saudi J Biol Sci. 2020 Jul;27(7):1753-1759. (PMID: 32565692) Cancer Nanotechnol. 2013;4(6):137-143. (PMID: 26069509) J Biomed Nanotechnol. 2014 Mar;10(3):478-84. (PMID: 24730243) Cancer Drug Resist. 2021;4:784-804. (PMID: 34993424) J Environ Sci (China). 2015 Mar 1;29:151-7. (PMID: 25766024) Int J Nanomedicine. 2018 Nov 27;13:8013-8024. (PMID: 30568442) Int J Oncol. 2002 Jul;21(1):111-7. (PMID: 12063557) Biotechnol Rep (Amst). 2019 Apr 30;23:e00339. (PMID: 31467862) Colloids Surf B Biointerfaces. 2022 Feb;210:112254. (PMID: 34896692) Indian J Microbiol. 2015 Jun;55(2):168-74. (PMID: 25805903) Front Microbiol. 2020 May 27;11:1074. (PMID: 32670214) Oxid Med Cell Longev. 2018 Aug 16;2018:8251961. (PMID: 30186549) J Nanobiotechnology. 2018 Oct 30;16(1):84. (PMID: 30373622) J Fungi (Basel). 2020 Oct 13;6(4):. (PMID: 33066193) J Photochem Photobiol B. 2015 Aug;149:84-92. (PMID: 26057018) Saudi J Biol Sci. 2019 Jan;26(1):148-154. (PMID: 30622419) Int J Nanomedicine. 2013;8:4303-14. (PMID: 24235828) Genet Mol Res. 2014 Mar 19;13(3):7022-8. (PMID: 24682984) J Environ Sci (China). 2017 May;55:157-163. (PMID: 28477809) Nanoscale Res Lett. 2016 Dec;11(1):300. (PMID: 27316741) J Funct Biomater. 2020 Nov 26;11(4):. (PMID: 33255874) J Ayurveda Integr Med. 2020 Jan - Mar;11(1):37-44. (PMID: 30120058) Nanoscale Adv. 2018 Dec 4;1(5):1707-1713. (PMID: 36134229) IET Nanobiotechnol. 2018 Jun;12(4):491-495. (PMID: 29768235) Nanomaterials (Basel). 2020 Jan 27;10(2):. (PMID: 32012732) Mater Sci Eng C Mater Biol Appl. 2016 Jan 1;58:36-43. (PMID: 26478284) ACS Omega. 2022 Sep 20;7(39):34770-34778. (PMID: 36211074) Toxicol In Vitro. 2013 Feb;27(1):330-8. (PMID: 22940466) Ecotoxicol Environ Saf. 2018 Dec 30;166:71-77. (PMID: 30248563) Molecules. 2022 Mar 21;27(6):. (PMID: 35335369) Environ Sci Pollut Res Int. 2018 Dec;25(34):34247-34261. (PMID: 30291612) Sci Rep. 2018 Sep 25;8(1):14368. (PMID: 30254325) Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):2846-2854. (PMID: 31299869) Int J Mol Sci. 2018 Dec 18;19(12):. (PMID: 30567324) Artif Cells Nanomed Biotechnol. 2017 Aug;45(5):1029-1035. (PMID: 27357085) Mater Sci Eng C Mater Biol Appl. 2020 Feb;107:110207. (PMID: 31761206) Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1556-1567. (PMID: 27900878) J Virol Methods. 2013 Nov;193(2):470-7. (PMID: 23886562) Nanomaterials (Basel). 2020 Aug 09;10(8):. (PMID: 32784939) RSC Adv. 2021 Jan 13;11(5):2804-2837. (PMID: 35424248) Appl Biochem Biotechnol. 2023 Jan;195(1):264-282. (PMID: 36074235) J Nanobiotechnology. 2010 Jan 20;8:1. (PMID: 20145735) J Biol Inorg Chem. 2020 Feb;25(1):23-37. (PMID: 31641851) J Photochem Photobiol B. 2018 Apr;181:122-126. (PMID: 29550670) Microbiol Res. 2016 Nov;192:52-64. (PMID: 27664723) Sci Rep. 2019 Apr 8;9(1):5787. (PMID: 30962456) J Photochem Photobiol B. 2020 Apr;205:111836. (PMID: 32172135) Int J Mol Sci. 2013 Aug 14;14(8):16732-801. (PMID: 23949635) Environ Res. 2020 Jun;185:109433. (PMID: 32247152) Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110901. (PMID: 32409057) Nanomicro Lett. 2021 Sep 13;13(1):193. (PMID: 34515917) BMC Nephrol. 2013 Apr 25;14:96. (PMID: 23617532) Int J Nanomedicine. 2020 Apr 17;15:2555-2562. (PMID: 32368040) J Genet Eng Biotechnol. 2018 Jun;16(1):105-113. (PMID: 30647712) Nanotoxicology. 2018 Sep;12(7):781-795. (PMID: 29996704) Microb Pathog. 2020 Jul;144:104172. (PMID: 32224208) Artif Cells Nanomed Biotechnol. 2018 Feb;46(1):160-168. (PMID: 28368661) Int J Mol Sci. 2021 May 17;22(10):. (PMID: 34067696) RSC Adv. 2018 Jun 25;8(41):23213-23229. (PMID: 35540173) Biomolecules. 2021 Oct 07;11(10):. (PMID: 34680114) J Adv Res. 2016 Jan;7(1):17-28. (PMID: 26843966) ACS Omega. 2022 Jul 25;7(31):27216-27229. (PMID: 35967026) Heliyon. 2020 Mar 19;6(3):e03624. (PMID: 32215333) J Nanostructure Chem. 2022;12(5):809-831. (PMID: 35070207) Cancers (Basel). 2020 Mar 12;12(3):. (PMID: 32178476) Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:902-912. (PMID: 30184820) Perspect Medicin Chem. 2014 Aug 28;6:25-64. (PMID: 25232278) Int J Nanomedicine. 2020 Nov 19;15:9159-9180. (PMID: 33244232) Mater Sci Eng C Mater Biol Appl. 2016 May;62:553-7. (PMID: 26952458) Mater Sci Eng C Mater Biol Appl. 2020 Mar;108:110421. (PMID: 31923969) Int J Nanomedicine. 2016 Dec 08;11:6679-6692. (PMID: 27994464) Mater Sci Eng C Mater Biol Appl. 2018 Aug 1;89:429-443. (PMID: 29752116) Mater Sci Eng C Mater Biol Appl. 2018 Oct 1;91:881-898. (PMID: 30033323) |
فهرسة مساهمة: | Keywords: Antibiotics; Green approach; Plant extract; Silver nanoparticles; cancer |
المشرفين على المادة: | 3M4G523W1G (Silver) 0 (Anti-Infective Agents) 0 (Plant Extracts) 0 (Antineoplastic Agents) |
تواريخ الأحداث: | Date Created: 20230905 Date Completed: 20240611 Latest Revision: 20240614 |
رمز التحديث: | 20240614 |
مُعرف محوري في PubMed: | PMC11166857 |
DOI: | 10.1007/s12010-023-04719-z |
PMID: | 37668757 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1559-0291 |
---|---|
DOI: | 10.1007/s12010-023-04719-z |